[Federal Register Volume 84, Number 219 (Wednesday, November 13, 2019)]
[Notices]
[Pages 61633-61634]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24636]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Clinical Care Commission

AGENCY: Office of Disease Prevention and Health Promotion, Office of 
the Assistant Secretary for Health, Office of the Secretary, Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Clinical Care Commission (the Commission) will 
conduct its fifth meeting on Friday, November 22, 2019. The Commission 
is charged to evaluate and make recommendations to the U.S. Department 
of Health and Human Services (HHS) Secretary and Congress regarding 
improvements to the coordination and leveraging of federal programs 
related to awareness and clinical care for complex metabolic or 
autoimmune diseases that result from issues related to insulin that 
represent a significant disease burden in the United States, which may 
include complications due to such diseases.

DATES: The meeting will take place on Friday, November 22, 2019, from 
8:00 a.m. to approximately 4:00 p.m. Eastern Time (ET).

[[Page 61634]]


ADDRESSES: The public meeting will be held at the Bethesda North 
Marriott Hotel and Conference Center, 5701 Marinelli Rd., Rockville, MD 
20852; 301-822-9200. The meeting will also be held online via webcast. 
To pre-register to attend the meeting, please visit the registration 
website at https://events.kauffmaninc.com/events/nccc5/.

FOR FURTHER INFORMATION CONTACT: Linda Harris, Designated Federal 
Officer, National Clinical Care Commission, U.S. Department of Health 
and Human Services, Office of the Assistant Secretary for Health, 
Office of Disease Prevention and Health Promotion, 1101 Wootton 
Parkway, Suite 420, Rockville, MD 20852. Email: [email protected].

SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act 
(Pub. L. 115-80) requires the HHS Secretary to establish the National 
Clinical Care Commission. The Commission consists of representatives of 
specific federal agencies and non-federal individuals and entities who 
represent diverse disciplines and views. The Commission will evaluate 
and make recommendations to the HHS Secretary and Congress regarding 
improvements to the coordination and leveraging of federal programs 
related to awareness and clinical care for complex metabolic or 
autoimmune diseases that result from issues related to insulin that 
represent a significant disease burden in the United States, which may 
include complications due to such diseases. During this fifth meeting, 
the Commission will hear from informants from selected federal agencies 
about programs related to diabetes prevention, treatment and discuss 
potential topics for the Commission's final report. The final meeting 
agenda will be available prior to the meeting at https://health.gov/hcq/national-clinical-care-commission.asp.
    Public Participation at Meeting: The Commission invites public 
comment on issues related to the Commission's charge either in-person 
at the meeting or in writing. In-person attendees who plan to provide 
oral comments at the Commission meeting during a designated time must 
submit their comments to [email protected] on or before November 15, 2019 and 
must check-in on-site. To accommodate as many individuals as possible, 
the time for each comment will be limited to three minutes. If more 
requests are received than can be accommodated, speakers will be 
randomly selected. The nature of the comments will not be considered in 
making this selection.
    Written comments are welcome throughout the entire development 
process of the Commission's recommendation and may be emailed to 
[email protected], or by mail to the following address: Public Commentary, 
National Clinical Care Commission, 1101 Wootton Parkway, Suite 420, 
Rockville, MD 20852. Written comments should not exceed three pages in 
length. Individuals who need special assistance, such as sign language 
interpretation or other reasonable accommodations, should indicate the 
special accommodation when registering online or by notifying Jennifer 
Gillissen at [email protected] by November 15.
    Authority: The National Clinical Care Commission is required under 
the National Clinical Care Commission Act (Pub. L. 115-80). The 
Commission is governed by provisions of the Federal Advisory Committee 
Act (FACA), Public Law 92-463, as amended (5 U.S.C., App.) which sets 
forth standards for the formation and use of federal advisory 
committees.

    Dated: November 5, 2019.
Donald Wright,
Deputy Assistant Secretary for Health, Disease Prevention and Health 
Promotion.
[FR Doc. 2019-24636 Filed 11-12-19; 8:45 am]
BILLING CODE 4150-32-P